IN2015DN01093A - - Google Patents
Info
- Publication number
- IN2015DN01093A IN2015DN01093A IN1093DEN2015A IN2015DN01093A IN 2015DN01093 A IN2015DN01093 A IN 2015DN01093A IN 1093DEN2015 A IN1093DEN2015 A IN 1093DEN2015A IN 2015DN01093 A IN2015DN01093 A IN 2015DN01093A
- Authority
- IN
- India
- Prior art keywords
- mini
- granule
- mini tablets
- composition
- tablets
- Prior art date
Links
- 239000008185 minitablet Substances 0.000 abstract 4
- 239000008187 granular material Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000003781 beta lactamase inhibitor Substances 0.000 abstract 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12182026 | 2012-08-28 | ||
| PCT/EP2013/067599 WO2014033077A1 (en) | 2012-08-28 | 2013-08-26 | Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01093A true IN2015DN01093A (enrdf_load_stackoverflow) | 2015-06-26 |
Family
ID=46963435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1093DEN2015 IN2015DN01093A (enrdf_load_stackoverflow) | 2012-08-28 | 2013-08-26 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150238425A1 (enrdf_load_stackoverflow) |
| EP (1) | EP2890366A1 (enrdf_load_stackoverflow) |
| CN (1) | CN104582692A (enrdf_load_stackoverflow) |
| IN (1) | IN2015DN01093A (enrdf_load_stackoverflow) |
| WO (1) | WO2014033077A1 (enrdf_load_stackoverflow) |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6024766B2 (ja) | 1978-03-23 | 1985-06-14 | 東洋醸造株式会社 | 徐放性抗生物質錠 |
| GB2176999B (en) | 1985-06-22 | 1989-07-12 | Stanley Stewart Davis | Sustained release medicament |
| US5430037A (en) * | 1988-11-25 | 1995-07-04 | Henning Berlin Gmbh Chemie -Und Pharmawerk | Oxypurinol alkali and alkalane earth salts in amorphous or crystalline form as agents for treating hyperuricaemia and gout |
| IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
| EP1023065A1 (en) * | 1997-08-29 | 2000-08-02 | Dsm N.V. | Granules free of excipients |
| TR199901584T1 (xx) * | 1997-11-17 | 2000-01-21 | Gist-Brocades B.V. | Klavulanat ve bir veya daha fazla ek madde içeren granüller |
| US6756057B2 (en) * | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
| GB0031267D0 (en) | 2000-12-21 | 2001-01-31 | Smithkline Beecham Plc | Novel compositions |
| AU2003255874A1 (en) | 2002-08-16 | 2004-03-03 | Orchid Health Care, A Division Of Orchid Chemicals And Pharmaceuticals Ltd. | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| RS20060413A (en) * | 2004-01-06 | 2008-11-28 | Panacea Biotec Ltd., | Non-disintegrating oral solid composition of high dose of water soluble drugs |
| WO2005099672A1 (en) | 2004-04-13 | 2005-10-27 | Ranbaxy Laboratories Limited | A modified release pharmaceutical formulation comprising amoxicillin and clavulanate |
| CA2572292A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
| US20060099253A1 (en) * | 2004-10-20 | 2006-05-11 | Wyeth | Antibiotic product formulation |
| WO2006092295A1 (en) * | 2005-03-02 | 2006-09-08 | Kairosmed Gmbh | Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support |
| AU2006235483B2 (en) | 2005-04-12 | 2010-11-25 | Elan Pharma International Limited | Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection |
| EP1915139A1 (en) | 2005-05-16 | 2008-04-30 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising a cephalosporin |
| WO2007059916A2 (en) | 2005-11-23 | 2007-05-31 | Sandoz Ag | Pharmaceutical composition |
| DE102006007830A1 (de) * | 2006-02-17 | 2007-08-30 | Grünenthal GmbH | Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure |
| WO2007106957A1 (en) | 2006-03-21 | 2007-09-27 | Laboratoires Smb S.A. | Multiple units controlled-release floating dosage forms |
| KR20090006123A (ko) * | 2006-03-24 | 2009-01-14 | 파나세아 바이오테크 리미티드 | 변형방출 항생물질 조성물 및 이의 조성방법 |
| WO2008031782A1 (en) | 2006-09-12 | 2008-03-20 | Glaxo Group Limited | Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor xa inhibitor |
| PL2120878T3 (pl) * | 2007-02-09 | 2015-01-30 | Alphapharm Pty Ltd | Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych |
| US20120027855A1 (en) | 2007-07-06 | 2012-02-02 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
| EP2837378A1 (en) | 2007-07-06 | 2015-02-18 | Lupin Limited | Pharmaceutical compositions of rifaximin |
| US20120003312A1 (en) | 2010-06-30 | 2012-01-05 | Aptapharma, Inc. | Multilayer Minitablets with Different Release Rates |
-
2013
- 2013-08-26 IN IN1093DEN2015 patent/IN2015DN01093A/en unknown
- 2013-08-26 CN CN201380044640.6A patent/CN104582692A/zh active Pending
- 2013-08-26 US US14/420,966 patent/US20150238425A1/en not_active Abandoned
- 2013-08-26 WO PCT/EP2013/067599 patent/WO2014033077A1/en active Application Filing
- 2013-08-26 EP EP13756078.5A patent/EP2890366A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20150238425A1 (en) | 2015-08-27 |
| CN104582692A (zh) | 2015-04-29 |
| EP2890366A1 (en) | 2015-07-08 |
| WO2014033077A1 (en) | 2014-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL231203A (en) | Selective and reversible inhibitors of ubiquitin-specific Protease 7, their pharmaceutical preparations and therapeutic applications | |
| IL232113A (en) | Boron-containing compounds, pharmaceuticals containing them and their use in inhibiting arginase | |
| MX338515B (es) | Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio. | |
| IL232038A (en) | Nephrilicin-inhibiting compounds containing oxalil, a process for obtaining them, and pharmaceuticals containing them | |
| PL2938362T3 (pl) | Proces granulacji na sucho do wytwarzania tabletkowych kompozycji metforminy i ich kompozycje | |
| IN2015DN03795A (enrdf_load_stackoverflow) | ||
| MX2014011825A (es) | INHIBIDORES DE ISOXAZOL ß-LACTAMASA. | |
| IL220863A (en) | Oxazole derivatives of kinase inhibitors, medicinal preparations containing them and their uses | |
| IL237321A0 (en) | ddr2 inhibitors and pharmaceutical preparations containing them | |
| EP2776059A4 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING PROTEASES AND METHODS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES | |
| IL222771A (en) | Manufacture of granules without active substance and tablets containing them | |
| MX353061B (es) | Nuevos comprimidos de meloxicam de baja concentracion. | |
| EP2626071A4 (en) | APPLICATIONS OF ARCTIGENIN FOR THE FORMULATION OF MEDICAMENTS FOR THE PROPHYLAXIS OR THE TREATMENT OF DISEASES RELATED TO THE REDUCTION OF RED BLOOD BODIES | |
| IL237322A0 (en) | Solid pharmaceutical preparations containing levothyroxine and their preparation | |
| IL241540A (en) | Preparations containing digestive enzymes and nutrients suitable for internal insertion | |
| SMT201900076T1 (it) | Composizione farmaceutica contenente una miscela di proenzimi e di enzimi | |
| IL227024A (en) | The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them | |
| TR201009167A2 (tr) | Sefalosporin içeren farmasötik granüller. | |
| RS20130034A1 (en) | PHARMACEUTICAL MIXTURE FOR LONG TERMETASIDINE RELEASE | |
| GEP201706675B (en) | Imidazo-triazine derivatives as pde10 inhibitors | |
| IN2013MU02911A (enrdf_load_stackoverflow) | ||
| MX2013013079A (es) | Composiciones que comprenden un agente antibacterial y tazobactam. | |
| NZ715615A (en) | Pharmaceutical compositions of ranolazine and dronedarone | |
| TR201011148A1 (tr) | Levetirasetam farmasötik bileşimleri. | |
| IN2015DN01093A (enrdf_load_stackoverflow) |